ECRI Institute today surgical stapler misuse as the leading health technology safety concern. In March, the Food and Drug Administration issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. ECRI said other leading health technology risks include: point-of-care ultrasound; sterile processing in medical and dental offices; hemodialysis with central venous catheters; unproven surgical robotic procedures; alarm, alert and notification overload; cybersecurity in the connected home health care environment; missing patient implant data for magnetic resonance imaging; medication dose timing discrepancies in electronic health records; and loose medical device components. 

Related News Articles

Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
There have been 8,064 reported cases of whooping cough in the U.S. so far this year, according to the latest data from the Centers for Disease Control and…
Headline
A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and carbapenem-resistant A. baumannii infections…
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
The incidence of invasive group A strep infections increased from 3.6 to 8.2 cases per 100,000 people from 2013 to 2022, according to a study authored by the…